Intra-abdominal Infection Treatment Drugs Market, Global Outlook and Forecast 2022-2028

January 2022 | 62 pages | ID: IAB4FBDB009FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Intra-abdominal Infection Treatment Drugs in Global, including the following market information:

Global Intra-abdominal Infection Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Intra-abdominal Infection Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chloramphenicol Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Intra-abdominal Infection Treatment Drugs include AstraZeneca, Merck, Pfizer, AtoxBio, Dainippon Sumitomo Pharma, Bayer, Bristol-Myers Squibb, Mylan Pharmaceuticals Inc. and Sun Pharmaceutical Industries, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intra-abdominal Infection Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Intra-abdominal Infection Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Intra-abdominal Infection Treatment Drugs Market Segment Percentages, by Type, 2021 (%)

• Chloramphenicol
• Beta Lactums
• Quinolones
• Aminoglycosides
• Others

Global Intra-abdominal Infection Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Intra-abdominal Infection Treatment Drugs Market Segment Percentages, by Application, 2021 (%)

• Intra-abdominal Abscess
• Appendicitis
• Diverticulitis
• Diarrhea
• Food Poisoning
• Infection by Helicobacter Pylori

Global Intra-abdominal Infection Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Intra-abdominal Infection Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Intra-abdominal Infection Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Intra-abdominal Infection Treatment Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Merck
• Pfizer
• AtoxBio
• Dainippon Sumitomo Pharma
• Bayer
• Bristol-Myers Squibb
• Mylan Pharmaceuticals Inc.
• Sun Pharmaceutical Industries, Inc.
• Teva Pharmaceutical Industries
• Dr. Reddy’s Laboratories
• Roche Holding AG
• GlaxoSmithKline
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Intra-abdominal Infection Treatment Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Intra-abdominal Infection Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INTRA-ABDOMINAL INFECTION TREATMENT DRUGS OVERALL MARKET SIZE

2.1 Global Intra-abdominal Infection Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Intra-abdominal Infection Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Intra-abdominal Infection Treatment Drugs Players in Global Market
3.2 Top Global Intra-abdominal Infection Treatment Drugs Companies Ranked by Revenue
3.3 Global Intra-abdominal Infection Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Intra-abdominal Infection Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Intra-abdominal Infection Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Intra-abdominal Infection Treatment Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Intra-abdominal Infection Treatment Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Intra-abdominal Infection Treatment Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Intra-abdominal Infection Treatment Drugs Market Size Markets, 2021 & 2028
  4.1.2 Chloramphenicol
  4.1.3 Beta Lactums
  4.1.4 Quinolones
  4.1.5 Aminoglycosides
  4.1.6 Others
4.2 By Type - Global Intra-abdominal Infection Treatment Drugs Revenue & Forecasts
  4.2.1 By Type - Global Intra-abdominal Infection Treatment Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Intra-abdominal Infection Treatment Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Intra-abdominal Infection Treatment Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Intra-abdominal Infection Treatment Drugs Market Size, 2021 & 2028
  5.1.2 Intra-abdominal Abscess
  5.1.3 Appendicitis
  5.1.4 Diverticulitis
  5.1.5 Diarrhea
  5.1.6 Food Poisoning
  5.1.7 Infection by Helicobacter Pylori
5.2 By Application - Global Intra-abdominal Infection Treatment Drugs Revenue & Forecasts
  5.2.1 By Application - Global Intra-abdominal Infection Treatment Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Intra-abdominal Infection Treatment Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Intra-abdominal Infection Treatment Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Intra-abdominal Infection Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Intra-abdominal Infection Treatment Drugs Revenue & Forecasts
  6.2.1 By Region - Global Intra-abdominal Infection Treatment Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Intra-abdominal Infection Treatment Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Intra-abdominal Infection Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Intra-abdominal Infection Treatment Drugs Revenue, 2017-2028
  6.3.2 US Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.3.3 Canada Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.3.4 Mexico Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Intra-abdominal Infection Treatment Drugs Revenue, 2017-2028
  6.4.2 Germany Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.4.3 France Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.4.4 U.K. Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.4.5 Italy Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.4.6 Russia Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.4.8 Benelux Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Intra-abdominal Infection Treatment Drugs Revenue, 2017-2028
  6.5.2 China Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.5.3 Japan Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.5.4 South Korea Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.5.6 India Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Intra-abdominal Infection Treatment Drugs Revenue, 2017-2028
  6.6.2 Brazil Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.6.3 Argentina Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Intra-abdominal Infection Treatment Drugs Revenue, 2017-2028
  6.7.2 Turkey Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.7.3 Israel Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028
  6.7.5 UAE Intra-abdominal Infection Treatment Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.1.4 AstraZeneca Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.2.4 Merck Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.3.4 Pfizer Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 AtoxBio
  7.4.1 AtoxBio Corporate Summary
  7.4.2 AtoxBio Business Overview
  7.4.3 AtoxBio Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.4.4 AtoxBio Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.4.5 AtoxBio Key News
7.5 Dainippon Sumitomo Pharma
  7.5.1 Dainippon Sumitomo Pharma Corporate Summary
  7.5.2 Dainippon Sumitomo Pharma Business Overview
  7.5.3 Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.5.4 Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.5.5 Dainippon Sumitomo Pharma Key News
7.6 Bayer
  7.6.1 Bayer Corporate Summary
  7.6.2 Bayer Business Overview
  7.6.3 Bayer Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.6.4 Bayer Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.6.5 Bayer Key News
7.7 Bristol-Myers Squibb
  7.7.1 Bristol-Myers Squibb Corporate Summary
  7.7.2 Bristol-Myers Squibb Business Overview
  7.7.3 Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.7.4 Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.7.5 Bristol-Myers Squibb Key News
7.8 Mylan Pharmaceuticals Inc.
  7.8.1 Mylan Pharmaceuticals Inc. Corporate Summary
  7.8.2 Mylan Pharmaceuticals Inc. Business Overview
  7.8.3 Mylan Pharmaceuticals Inc. Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.8.4 Mylan Pharmaceuticals Inc. Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.8.5 Mylan Pharmaceuticals Inc. Key News
7.9 Sun Pharmaceutical Industries, Inc.
  7.9.1 Sun Pharmaceutical Industries, Inc. Corporate Summary
  7.9.2 Sun Pharmaceutical Industries, Inc. Business Overview
  7.9.3 Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.9.4 Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.9.5 Sun Pharmaceutical Industries, Inc. Key News
7.10 Teva Pharmaceutical Industries
  7.10.1 Teva Pharmaceutical Industries Corporate Summary
  7.10.2 Teva Pharmaceutical Industries Business Overview
  7.10.3 Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.10.4 Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.10.5 Teva Pharmaceutical Industries Key News
7.11 Dr. Reddy’s Laboratories
  7.11.1 Dr. Reddy’s Laboratories Corporate Summary
  7.11.2 Dr. Reddy’s Laboratories Business Overview
  7.11.3 Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.11.4 Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.11.5 Dr. Reddy’s Laboratories Key News
7.12 Roche Holding AG
  7.12.1 Roche Holding AG Corporate Summary
  7.12.2 Roche Holding AG Business Overview
  7.12.3 Roche Holding AG Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.12.4 Roche Holding AG Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.12.5 Roche Holding AG Key News
7.13 GlaxoSmithKline
  7.13.1 GlaxoSmithKline Corporate Summary
  7.13.2 GlaxoSmithKline Business Overview
  7.13.3 GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.13.4 GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.13.5 GlaxoSmithKline Key News
7.14 Sanofi
  7.14.1 Sanofi Corporate Summary
  7.14.2 Sanofi Business Overview
  7.14.3 Sanofi Intra-abdominal Infection Treatment Drugs Major Product Offerings
  7.14.4 Sanofi Intra-abdominal Infection Treatment Drugs Revenue in Global Market (2017-2022)
  7.14.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Intra-abdominal Infection Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Intra-abdominal Infection Treatment Drugs Market Drivers in Global Market
Table 3. Intra-abdominal Infection Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Intra-abdominal Infection Treatment Drugs in Global Market
Table 5. Top Intra-abdominal Infection Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Intra-abdominal Infection Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Intra-abdominal Infection Treatment Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Intra-abdominal Infection Treatment Drugs Product Type
Table 9. List of Global Tier 1 Intra-abdominal Infection Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intra-abdominal Infection Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Intra-abdominal Infection Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Intra-abdominal Infection Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Intra-abdominal Infection Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Intra-abdominal Infection Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Intra-abdominal Infection Treatment Drugs Product Offerings
Table 32. AstraZeneca Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Intra-abdominal Infection Treatment Drugs Product Offerings
Table 35. Merck Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Intra-abdominal Infection Treatment Drugs Product Offerings
Table 38. Pfizer Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 39. AtoxBio Corporate Summary
Table 40. AtoxBio Intra-abdominal Infection Treatment Drugs Product Offerings
Table 41. AtoxBio Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Dainippon Sumitomo Pharma Corporate Summary
Table 43. Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Product Offerings
Table 44. Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Bayer Corporate Summary
Table 46. Bayer Intra-abdominal Infection Treatment Drugs Product Offerings
Table 47. Bayer Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Corporate Summary
Table 49. Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Product Offerings
Table 50. Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Mylan Pharmaceuticals Inc. Corporate Summary
Table 52. Mylan Pharmaceuticals Inc. Intra-abdominal Infection Treatment Drugs Product Offerings
Table 53. Mylan Pharmaceuticals Inc. Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Sun Pharmaceutical Industries, Inc. Corporate Summary
Table 55. Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Product Offerings
Table 56. Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Teva Pharmaceutical Industries Corporate Summary
Table 58. Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Product Offerings
Table 59. Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Dr. Reddy’s Laboratories Corporate Summary
Table 61. Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Product Offerings
Table 62. Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Roche Holding AG Corporate Summary
Table 64. Roche Holding AG Intra-abdominal Infection Treatment Drugs Product Offerings
Table 65. Roche Holding AG Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 66. GlaxoSmithKline Corporate Summary
Table 67. GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Product Offerings
Table 68. GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Sanofi Corporate Summary
Table 70. Sanofi Intra-abdominal Infection Treatment Drugs Product Offerings
Table 71. Sanofi Intra-abdominal Infection Treatment Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Intra-abdominal Infection Treatment Drugs Segment by Type in 2021
Figure 2. Intra-abdominal Infection Treatment Drugs Segment by Application in 2021
Figure 3. Global Intra-abdominal Infection Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Intra-abdominal Infection Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Intra-abdominal Infection Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Intra-abdominal Infection Treatment Drugs Revenue in 2021
Figure 8. By Type - Global Intra-abdominal Infection Treatment Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Intra-abdominal Infection Treatment Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Intra-abdominal Infection Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Intra-abdominal Infection Treatment Drugs Revenue Market Share, 2017-2028
Figure 12. US Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Intra-abdominal Infection Treatment Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Intra-abdominal Infection Treatment Drugs Revenue Market Share, 2017-2028
Figure 24. China Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Intra-abdominal Infection Treatment Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Intra-abdominal Infection Treatment Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Intra-abdominal Infection Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AtoxBio Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bayer Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Mylan Pharmaceuticals Inc. Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Roche Holding AG Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Sanofi Intra-abdominal Infection Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)